Online Educational Activity

Navigating the Evolving Therapeutic Landscape for Diabetes Management: Addressing Implications for Clinical Practice CME Peer-to-Peer Dialogue and FAQs

Needs Statement/intended Audience

This educational activity is designed for physicians, doctors of osteopathy, family physicians, podiatric physicians, physician assistants, nurses, nurse practitioners, dietitians, pharmacists, psychologists, certified diabetes educators, and other health care professionals who care for patients with diabetes and who manage the complications related to this disease.

Educational Activity Learning Objectives

After participating in this educational curriculum, health care professionals should be able to:

• Assess the unique benefits and risks associated with newer antiglycemic therapies, including their use in combination with other classes of medication for glycemic control
• Describe the latest clinical trial results and unique clinical endpoints examining the effects of antiglycemic therapies on emerging strategies to get to A1C goals
• Define the effects of antiglycemic therapies on beta cell function and discuss why this may be an important consideration for the management and prevention of diabetes

Credit Statement

The France Foundation designates each podcast educational activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CME Peer-to-Peer Dialogue

CME Peer-to-Peer Dialogue features insightful audio commentary from a prestigious group of experts in diabetes management. Listen in for state-of-the-art information as they address timely, clinically relevant topics.

Faculty

Ralph A. DeFronzo, MD (Chairperson)
Professor of Medicine
Chief of the Diabetes Division
University of Texas Health Science Center
Audie L. Murphy Memorial VA Hospital
San Antonio, Texas

Patrick J. Boyle, MD
Professor of Medicine
Lead Physician, Diabetes Care Management Team
University of New Mexico
Albuquerque, New Mexico

Richard E. Pratley, MD
Professor of Medicine
Director, Diabetes and Metabolism Translational Medicine Unit
University of Vermont College of Medicine
Colchester Research Facility
Colchester, Vermont

Release/Expiration Dates

This activity is eligible for CME credit from March 2009 through March 31, 2010.

Commercial Support Acknowledgment

This program is supported by an educational grant from Takeda Pharmaceuticals North America, Inc.

For more informaton, visit www.diabetesdialogue.com